Menu
Washingtoner
  • Home
  • Artificial Intelligence
  • Health
  • Technology
  • Entertainment
  • Software
  • Real Estate
  • Business
  • Education
Washingtoner

Axis International Showcases the RLT Body Suit—A Patented Concept for Wearable Full-Body Red Light Therapy
Washingtoner/10330881

Trending...
  • Global Leaders Convene in Seattle to Advance Responsible AI and Cross-Border Ecosystems
  • AI Needs Guardrails Now: A New Movement Asks People Everywhere to Take the Pledge
  • RAS AP Consulting Advances 1099 Education and Readiness Initiative Through IFOL Training and Finance Technology Showcase
Chatgpt Image Jul 21, 2026, 10 34 23 Am
CHICAGO - Washingtoner -- xis International is introducing the RLT Body Suit, an innovative patented concept designed to bring the benefits of red light therapy into a comfortable, wearable format.

Unlike conventional red light therapy systems that require users to remain stationary in front of treatment panels, the RLT Body Suit is designed to integrate therapy directly into a wearable garment. The concept features embedded light therapy technology, a rechargeable power system, and customizable intensity and timing controls, allowing users to personalize their therapy experience.

The wearable design is intended to support an active lifestyle while delivering full-body treatment in a convenient and portable solution.

More on Washingtoner
  • Spokane: Drugs and Guns Seized in a Counter Narcotics Investigation
  • Brian G. Miller Co., LLC Receives Tier 1 Ranking in the 2027 Edition of Best Law Firms®
  • The Villari Firm, PLLC Named to the 2027 Edition of Best Law Firms
  • Spokane: City and County Issue Joint Housing and Homelessness Funding RFP
  • Spokane: Council Approves Additional Funding to Prepare for Inclement Weather

Potential applications include muscle recovery, relaxation, wellness routines, post-exercise recovery, and everyday self-care.

As the wearable wellness industry continues to expand, innovative products that combine mobility, convenience, and advanced technology are attracting significant consumer interest. The RLT Body Suit represents a forward-looking concept that could appeal to manufacturers in the wellness, fitness, recovery, and medical technology markets.

Axis International is currently seeking licensing partners interested in bringing this patented concept to market.

For licensing information, visit: https://123axis.com/in-the-news/

Contact
ANDY BERGER
***@aol.com


Source: Axis International Marketing
Filed Under: Health

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on Washingtoner
  • Shiokly Launches Online Marketplace to Help Singapore Home-Based Businesses Sell More, With First Product Listed Free
  • Freight Broker 911 and Milton Collier Introduce "What's The 911?"—A New Podcast Built on Real Talk, Real Freight, and Real Opportunity
  • PropAccount.com Launches PropWallet, Turning Prop Firm Payouts Into Repeat Sales
  • Spokane: City And County Seek Federal Grant to Plan for Road Network Wildfire Resilience
  • The Great Junk Hunt Returns to Monroe: Kick Off Your Holiday Shopping at the Ultimate Vintage Treas
  • AI Trading Agents Track Aerospace and Defense US Stocks Amid Rising Technology Investment (SATS, GILT, TSAT, IREN, JOBY, LUNR)
  • KOLBUS America, For All Of Your Hycorr Equipment And Service Needs
  • Evluma's RoadMax Edge Roadway Luminaires Earn DarkSky Approved Status
  • Heritage at Hopewell Announces New 3.875% Year-One Mortgage Rate Buydown Incentive on Quick Delivery Townhomes (7.11% APR)
  • New TROP2 Research Breakthrough Strengthens REQORSA® Gene Therapy Story as Roche Collaboration Advances Precision Lung Cancer Treatment: Genprex, Inc
  • Tacoma: Public Hearing for Off-Street Parking Code Update Set for December 1
  • Rent a Truck or Hire Movers? New Data Shows Fuel Now Makes Up to 40% of DIY Moving Costs
  • Spokane: SPD Makes an Arrest in Yesterday's Early Morning Shooting
  • Spokane: Mayor Brown Introduces 2027-2028 Budget Proposal
  • Club Wyndham Research Identifies the "Holiday Rewind Effect": 93% of Parents Recreate Their Own Childhood Holidays for Their Kids
  • IEI Rugged IP66 Panel PC Brings Real-Time Visibility to Heavy-Duty Mining Fleets
  • FDA Approval; Major Milestone for Preservative-Free Ketamine Ahead of FDA Goal Date for Treatment of Suicidal Depression by NRx Pharmaceuticals, Inc
  • Building a Technology Powerhouse-From AI Drones and Global Acquisitions to Defense, Enterprise Software and the Future of Autonomous Operations $ZENA
  • Shelter Structures America backs MATRA Second Life Project to turn retired tent vinyl into homes for displaced families
  • P-Wave Press Announces Becoming Dad: Reflections for New Fathers by L. A. Davenport
_catLbl0 _catLbl1

Popular on Washingtoner

  • Spokane: City and Permittable Partner to Support Rebuilding After Wildfires - 307
  • Spokane: City to provide asbestos testing, host community resource meetings - 255
  • Tacoma: In-Person Workshop on October 22 for Local Businesses on the City’s Revolving Loan Fund Process - 212
  • Pre-Seed VC Martin Tobias Makes Fundraising Tool Available to Every Startup CEO as Investor Match - 182
  • Final Week to Register for Free Spokane Community Conference - 151
  • New Research Spotlight, Expanding TUSC2 Science & Strategic Development Milestones Put Gene Therapy Innovation into Focus for Genprex (NAS DAQ: GNPX) - 148
  • Citizens for West Virginia Election Integrity Urges "FOR" on Amendment 1 - 147
  • Geospatial Innovation Comes to Sacramento: FOSS4G NA 2026 - 115
  • Holiday Gambling Spending Expected to Rise 12% in December - 111
  • Author Robert A. Robinson Introduces Anarchy at the AYP: - 111

Similar on Washingtoner

  • New Omega-3 Fish Oil Under NIH Investigation: What Makes It Different From EPA and DHA?
  • OncoBeta Introduces Rhenium-SCT for Non-Melanoma Skin Cancer at Theageneio Cancer Hospital of Thessaloniki
  • New Patient Data Show REQORSA® Activating Cellular Repair Pathways as Roche Collaboration Advances Precision Lung Cancer Strategy for Genprex, Inc
  • New TROP2 Research Breakthrough Strengthens REQORSA® Gene Therapy Story as Roche Collaboration Advances Precision Lung Cancer Treatment: Genprex, Inc
  • FDA Approval; Major Milestone for Preservative-Free Ketamine Ahead of FDA Goal Date for Treatment of Suicidal Depression by NRx Pharmaceuticals, Inc
  • Haven Treatment Center Pays It Forward with Donation of 150 Food Boxes and Gift Cards to Evergreen
  • Major FDA Victory; Preservative-Free Ketamine Approved Ahead of November 10 Goal Date as Commercial Launch Opportunity Comes Into Focus for NRx Pharma
  • New Research Spotlight, Expanding TUSC2 Science & Strategic Development Milestones Put Gene Therapy Innovation into Focus for Genprex (NAS DAQ: GNPX)
  • Paraguay Expedition Offers a Different View of Human Resilience
  • Longevity Academy Features Gail Humble, MD of KLOTHO SKIN in the Longevity Leaders Project
Copyright © 2026 washingtoner.com | Terms of Service | Privacy Policy | Contact Us | Contribute